Monitoreo terapéutico de la clomipramina y sus desmetil y oximetabolitos en pacientes deprimidos: análisis farmacogenéticos y correlación con la respuesta clínica

Estévez Carrizo, Francisco E; Porciúncula, Horacio; Giusti Azzazi, Marcos J; Pellejero Arostegui, María T; Rivero Reinoso, Gonzalo; Dibarboure Rossini, Gabriela; Usher Guimil, Alvaro M; Yoo Demarco, Ivonne D; Ferrara Ciccarino, Rafael; Mendaro Curutchet, Gloria P.
Arch. med. interna (Montevideo) ; 21(4): 157-164, dic. 1999. tab, graf
Artículo en Español | LILACS | ID: lil-324964

Documentos relacionados

  1. Genetic Causal Associations between Various Serum Minerals and Risk of Depression: A Mendelian Randomization Study.
  2. Treatment-Resistant Depression in Argentina: results from a longitudinal analysis of the TRAL Study
  3. Low-Dose Ozone Therapy Improves Sleep Quality in Patients with Insomnia and Coronary Heart Disease by Elevating Serum BDNF and GABA.
  4. Gender difference in vitamin A levels in first-episode drug-naïve depression patients: a case-control and 24-weeks follow-up study.
  5. Antidepressant use and circulating prolactin levels.
  6. Monoamines and cortisol as potential mediators of the relationship between exercise and depressive symptoms.
  7. Effects of quercetin on the alterations of serum elements in chronic unpredictable mild stress-induced depressed rats.
  8. Atherogenic Index of Plasma as a Mediator in the association between Body Roundness Index and Depression: insights from NHANES 2005-2018.
  9. A model of dopamine and serotonin-kynurenine metabolism in cortisolemia: Implications for depression.
  10. Blue light filtered white light induces depression-like responses and temporary spatial learning deficits in rats.